|
|
|
|
|
|
|
Nantong Senxuan Pharmaceutical Co., Ltd., located at No.20-1, 3 Haibin Road, Yanhai Economic Development Zone, Rudong, a JV company held by Jiangsu Senxuan Pharmaceutical and Chemical Co., Ltd. and Jinhua Pharmaceutical Group Co., Ltd., was established in Oct. 2015, covering an area of 58000sqm, with total investment of 140 million RMB, started construction in March 2016 and completed and put into operation in May 2017, is mainly engaged in ethers, esters, intermediates for Ritonavir, intermediates of pharmaceuticals and APIs etc. Adhering to the development concepts of Jinhua Pharmaceutical Group and Jiangsu Senxuan, sticking to the principle of "environmental protection priority, safety first", Nantong Senxuan Pharmaceutical Co., Ltd., would become a significant production base for APIs and intermediates of Jinhua Pharmaceutical Group Co., Ltd. |
|
|
| 1,4-dioxane, 1,3-dioxolane, Ritonavir intermediates, 5-Hydroxymethylthiazole, NCT, MTV-III, BDH PURE, RIT-III, BDS 902146-43-4, Pharmaceutical intermediates, Azelaic acid, benzobarbital, 1-Benzyl-5-phenylbarbituric acid, Diethyl phenylmalonate, Ethyl Phenylacetate, Methyl phenylacetate, Ethyl-2-phenyl-2-cyanobutylate, p-methoxy phenylacetone , 4-Chlorophenyl ethanol, (S)-4-phenyl-2-oxazolidinone |
|
|
| Company : |
Nantong Senxuan Pharmaceutical Co.Ltd |
| Email: |
Contact us |
| URL: |
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
